These findings, alongside established knowledge of CHGA as a neuroendocrine marker [35], strongly support CHGA as a promising biomarker for HCC, warranting further investigation into its functional role and precise prognostic utility. This evidence concerns the gene CHGA and hepatocellular carcinoma.